Fearey Group CEO and president Aaron Blank explains how his online support group is seeking to help Seattle, Washington, businesses get through the coronavirus crisis.
Fearey Group CEO and president Aaron Blank explains how his online support group is seeking to help Seattle, Washington, businesses get through the coronavirus crisis.
(Bloomberg) -- The pound strengthened more than 1% against the dollar after the Scottish National Party’s election showing pushed back the risk of a near-term vote on independence, yet traders are bracing for further clashes over the U.K.’s future down the road.Sterling climbed by the most in almost a month to $1.4134 on Monday, its highest level since February, after the SNP fell one seat short of a parliamentary majority. Strategists from Rabobank International to Credit Agricole SA cite the push for a referendum -- which U.K. Prime Minister Boris Johnson opposes -- as a headwind that could create volatility in the months to come.“There are a lot of voices in the market that see the lack of a majority for the SNP combined with Johnson’s refusal to hold a referendum as meaning that the risks to the union are a non-issue for the pound,” said Jane Foley, head of foreign-exchange strategy at Rabobank. “I would be more cautious on this.”Investors will now be paying attention to how SNP’s leader Nicola Sturgeon pursues the goal of changing Scotland’s constitutional future. Her party boosted its haul to 64 of the 129 seats in the Scottish Parliament and, alongside the Green party that also increased its share, would have enough to form a pro-independence majority. Johnson has said that he would not grant one any time soon, which could lead to a clash in the courts.Sterling’s rally started during Asia as investors covered short positions and Japanese banks bought the currency, traders said, before extending through London trading. U.K. government bonds led a selloff of haven sovereign assets following the vote. Ten-year yields climbed as much as four basis points to 0.81%.The U.K. prime minister did strengthen his hand across Northern England, benefiting from the country’s speedy rollout of vaccines. Britain is due to be fully re-opened by June 21 and the corresponding economic boost could be another tailwind for the pound over the coming months. One-month risk reversals, a gauge of market sentiment, show pound traders are at their most bullish versus the dollar since last month.“’What matters is the U.K. economy, the Bank of England, the dollar and risk markets,” said James Athey, a money manager at Aberdeen Standard Investments. If the dollar suffers in coming months, sterling could rise as high as $1.45, a level last seen in 2016, he said.Read more: Why Scotland’s Road to Independence Vote Is RockyFor Rabobank’s Foley, continued uncertainties over Scotland’s future could spur volatility in sterling over the next 18 months. Sturgeon has said that if Johnson wants to stop Scottish legislation on a referendum, he would have to go to the Supreme Court to challenge it. A draft Referendum Bill has already been published. While a majority voted to remain in the union in 2014, odds show that a new referendum could be much tighter.“The pound is not out of the woods just yet,” said Valentin Marinov, head of Group-of-10 foreign-exchange research at Credit Agricole. “The confrontation over independence between Holyrood and Westminster could grow more intense in the wake of the Scottish election and thus add to the downside risks for sterling once again.”(Updates prices to reflect 1% rally from first paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Hong Kong's Cathay Pacific has raised $650 million in its first U.S. dollar bond in 25 years, a term sheet seen by Reuters showed on Monday. The deal consisted of 5.25-year senior unsecured notes priced with at 4.875%, the term sheet showed. Cathay did not immediately respond to a request for comment from Reuters.
(Bloomberg) -- The U.K. government is preparing to sell more than 1 billion pounds ($1.4 billion) of shares in NatWest Group Plc, further reducing its stake in the lender it bailed out during the 2008 financial crisis.The Treasury said Monday it plans to place 580 million shares, representing approximately 5% of NatWest’s overall stock, through an accelerated bookbuild. This will take the government’s stake down to 54.8%. A term sheet seen by Bloomberg News said the offering is valued at about 1.14 billion pounds. Shares in NatWest fell as much as 4% after Sky News earlier reported that Goldman Sachs Group Inc., which is advising the government on privatizations, has begun to sound out institutional investors about a possible disposal.The news comes two months after the Treasury sold 1.13 billion pounds-worth of stock to the bank, reducing its holding for the first time in almost three years. That sale took place at 190.5 pence per share.Barclays Plc, Citigroup Inc., Goldman Sachs and Morgan Stanley have been appointed to act as joint bookrunners on the sale, according to the statement. (Adds confirmation of sale from first paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
The S&P 500 and the Dow were set to open at record highs on Monday as optimism that interest rates would remain lower for longer lingered, while a surge in commodity prices lifted shares of miners, energy and steel companies. Copper miner Freeport-McMoran rose 3.4% in premarket trading, while aluminum producer Alcoa gained 3.4% and steelmaker United States Steel Corp was up 2.4% as copper prices touched a record high and aluminum scaled a new peak.
A number of investor advisory groups have called on AstraZeneca shareholders to oppose plans to increase Chief Executive Pascal Soriot's pay package when the COVID-19 vaccine maker holds its annual meeting on Tuesday. AstraZeneca developed one of the first vaccines to tackle the novel coronavirus but the Anglo-Swedish company has suffered a series of setbacks, with disputes over supplies to the European Union and concerns over the risk of rare blood clots. Frenchman Soriot, who has been in charge of AstraZeneca since 2012, received a total pay package worth 15.4 million pounds ($21.7 million) last year.
NEW YORK/LONDON/SINGAPORE (Reuters) -Cryptocurrency ethereum climbed to a new peak for a third straight day on Monday on continued optimism about further growth in decentralized finance or "DeFi", although some analysts said it was overvalued at current levels. Ethereum has soared this year, fuelled by the boom in DeFi, which are platforms that facilitate crypto-denominated lending outside traditional banking. Many DeFi applications are embedded in the ethereum blockchain.
In the past week, investors have had to cope with multiple conflicting signals from the markets. The April jobs report, which was expected to show almost 1 million new positions for the month, showed only 266,000. The official unemployment number ticked upward slightly to 6.1%, and hourly wages also gained – by 0.7%. That last would seem to be a positive – except that, combined with the massive government stimulus injecting cash into the economy – higher wages are seen as a portent of inflation. At first glance, it seems like an environment that would have investors cautious. Except – the Fed has signaled that it will not be winding down its easy money policies. Low interest rates have helped to fire up the bull market engine in recent years, for two reasons. First, it keeps the cost of credit low, making it easy to leverage all sorts of purchases – cars, homes… even stocks. And second, with rates low, bond yields have been unable to make any significant rise. For investors seeking a return, this makes stocks the place to go. It also creates an environment that’s conducive to IPO events. Markets have been on a steady, long-term upward trend for months; the S&P 500 has gained 44% over the last 12 months. With a return potential like that, it’s no wonder that companies are turning to the public trading markets to raise capital. When it comes to equities, a rising tide truly will lift all boats. This brings us to JPMorgan. The banking firm’s stock analysts have been looking for the equities primed to gain in current conditions. And they’ve tapped two stocks new to the public markets as likely to jump 80% or more in coming months – a solid return that investors should note. After running both tickers through TipRanks’ database, we found out that the rest of the Street is also standing squarely in the bull camp as each boasts a “Strong Buy” analyst consensus. LAVA Therapeutics (LVTX) We’ll start with a Netherlands-based biotech firm. LAVA Therapeutics has a focus on cancer treatments, and is working to develop what it calls gamma-delta bispecific T cell engagers. These compounds are intended to activate the innate and adaptive immune systems, using the body’s own response to fight tumors. LAVA’s pipeline includes four proprietary compounds, and a fifth that is being investigated in combination with Janssen. All five drug candidates are in preclinical trials. The leading candidate, LAVA-051, is scheduled to begin a Phase 1/2a clinical trial in the first half of this year, while a second candidate, LAVA-1207, will begin a Phase 1/2a trial during 2H21. These drug candidates are being developed as treatments for multiple myeloma and prostate cancer, respectively. LVTX shares entered the public markets on March 25, in an IPO that raised $100.5 million. The shares started trading at $15, and saw 6.7 million shares hit the market. Among the bulls is JPM analyst Jessica Fye, who likes the fundamental of this newly public stock. Fye rates LVTX an Overweight (i.e. Buy), and her $22 price target implies a robust upside potential of ~86% for the year ahead. (To watch Fye’s track record, click here) "Our Overweight rating is based on our positive view of the company’s proprietary platform, gamma-delta bsTCE, which redirects a specific group of T cells called gamma-delta T cells towards tumor cells. We see LAVA’s off-the-shelf bsTCEs, which can conditionally activate gamma-delta T cells in a tumor/antigen directed manner, as differentiated, potentially leading to a safer therapy and more durable benefit. To the extent that initial data for lead asset LAVA-051 begins to derisk the platform, we see upside for shares as soon as early 2022," Fye noted. In its short time on the public market, LAVA’s unique approach to cancer treatment has attracted notice from three Wall Street biotech analysts – and all three agree that this is a stock to buy, making the Strong Buy consensus rating unanimous. The shares are trading for $11.80, and their $23.67 average price target is even more bullish Fye allows, suggesting an upside of ~100% in the next 12 months. (See LVTX stock analysis on TipRanks) Zhihu (ZH) From biotech, let’s shift gears to online content. The net has given content creators a nearly unlimited field to work in, and Zhihu operates in the Chinese online content market. The company’s website is a question-and-answer forum, on the model of Quora, allowing users to pose questions to the community or offer replies. A look at some of the company’s numbers shows its size. By the end of December last year, Zhihu had a total of 43.1 million content creators, who has posted over 315 million questions and answers. The monthly average users (MAU), a key metric for any website, increased from 43.1 million in 4Q19 to 75.7 million in 4Q20. Zhihu held a US IPO on March 26, to raise capital for further operations and expansion. The company put 55 million shares on the American public markets, at $9.50 each. The IPO raised $522.5 million in gross proceeds, and Zhihu now shows a market cap of $4.58 billion. In their early trading, ZH shares faced pressure after a Securities and Exchange Commission ruling on accounting regulations. US law requires that accounting firms permit US regulators to review the financial audits of overseas companies, under threat of potential delisting from the US equity markets. The SEC ruling promises stricter enforcement of this provision. Even under this pressure, however, the Zhihu IPO was the third-largest by a Chinese company in the US markets so far this year. In an initiation of coverage report on Zhihu, JPM analyst Binbin Ding notes several factors that bode well for the stock, with two in particular standing out: “(1) Differentiated positioning. Unlike online content communities that are mostly entertainment-oriented, Zhihu is known for its depth of content and is recognized as the most trustworthy online content community in China (CIC survey). This positioning makes it the go-to platform for users seeking quality answers. (2) Diversified monetization models, including ads, membership, content-commerce solution, ecommerce and education. In particular, we believe Zhihu’s content-commerce solutions is an innovative model with significant potential growth upside…” Ding summed up, "We expect Zhihu to see a 112% top-line CAGR over 2020 to ’22E, driven by a 35% traffic CAGR and a 57% monetization CAGR. Such growth rates make Zhihu the fastest-growing digital content operator in our coverage universe." To this end, Ding gives ZH shares an Overweight (i.e. Buy) rating, along with a $16 price target that suggests room for an impressive 96% growth potential this year. (To watch Ding’s track record, click here) Ding's bullish stance on ZH is in line with Wall Street’s view. The stock has a Strong Buy consensus rating, based on 3 Buy ratings set in recent weeks. The shares are trading for $8.15, and their $15.23 average price target suggests ~87% upside for the year ahead. (See ZH stock analysis on TipRanks) To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.
Ether prices on the Ethereum blockchain have been steadily and quietly carving out new highs as buzz in the crypto has centered predominantly on the fervor around more speculative assets like dogecoin in recent weeks.
(Bloomberg) -- The owners of LBC Express Holdings Inc. are considering a stake sale in the Philippine delivery company amid interest from potential buyers, according to people familiar with the matter.LBC Express’ owners, which include the Araneta family and private equity firm Crescent Point, are in talks with investment banks to help find a buyer for as much as 40% of the business, the people said, asking not to be identified because the matter is private. A sale process could kick off later this year and some logistics companies and investment funds have expressed initial interest, one of the people said.Shares in LBC Express have risen about 13% in Manila in the past year. A 40% stake could be worth about $185 million based on the logistics firm’s market value on Monday.No final decision has been made and LBC Express’ owners could still decide against pursuing a sale, the people said. A representative for the Araneta family declined to comment, while a representative for Crescent Point didn’t immediately respond to requests for comment.Founded in 1945 by the Araneta family as a brokerage and air cargo agent, LBC Express now provides express delivery, cargo shipping and remittance services, according to its website. It has a network of more than 6,400 locations, partners and agents in more than 30 countries. The company went public on the Philippine stock exchange in 2001.Crescent Point became a minority shareholder in LBC Express through a $50 million convertible bond deal in 2017. The private equity firm focuses on investments in consumer-facing businesses across China and Southeast Asia, according to its website.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
A new professional service out of Wyoming can make sure your bitcoin (BTCUSD) billions or $100 million in “non-fungible tokens” pass to your heirs with the minimum of risk, fuss and, yep, federal, state or other taxes. This assumes, of course, that the digital currency mania—currently valued at around $2.4 trillion, or roughly as much as the entire German stock market — lasts longer than you do. “The IRS is going to view anyone’s digital asset holdings, whether it’s cryptocurrencies, NFTs etc., as property in the same way that they will view your stocks, or art, or wine,” explains Joel Revill, a former Wall Street banker now running Wyoming-based wealth management company Two Ocean.
President Biden has proposed taxing capital gains like ordinary income for those with incomes over $1,000,000. In addition to paying for his agenda, this proposal will make the federal income tax fairer, by ensuring that the wealthy pay their appropriate share of the tax bill, and more efficient, by eliminating the incentive to transform high-taxed ordinary income to low-taxed or untaxed capital gains.
The U.S. cannabis deal would give Florida’s dominant player a notable southwestern U.S. footprint. Trulieve (ticker: TCNNF) and Harvest Health (HRVSF) combined would be one of the largest cannabis companies in the world, in terms of sales. Combining analyst estimates for both companies puts the estimated 2021 revenue at $1.24 billion, only slightly below consensus estimates for Curaleaf (CURLF) at $1.26 billion.
Dogecoin's stratospheric run was in jeopardy early Sunday, with the popular crypto unwinding a chunk of its recent rally.
Trulieve Cannabis Corp. said Monday it has agreed to acquire Harvest Health & Recreation Inc. in an all-stock deal valued at about $2.1 billion, the latest tie-up in a sector hoping for reforms of strict U.S. cannabis laws that would crack open capital markets.
(Bloomberg) -- Honest Co.’s shares tumbled again on Monday, extending a slide just days after the consumer-goods company started by actress Jessica Alba made a splashy debut in the public markets.A decline of as much as 13% sent the shares as low as $16.52, approaching the initial public offering price of $16 on May 4. After soaring 44% on its first day of trading, the stock declined more than 7% in the next two sessions and was on pace Monday for its third straight drop.The slump is an inauspicious start for a company looking to capitalize on elevated demand for packaged-goods and cleaning supplies during the pandemic. Alba, who co-founded the direct-to-consumer brand in 2011 and now serves as chief creative officer, brought some Hollywood glamour to the IPO last week with multiple media appearances.There have been hints that the pandemic boom is starting to subside for packaged goods, with some peers reporting higher costs and uneven demand trends recently. Data and research company New Constructs called Honest “overvalued” and said the stock is “worth no more than $7” a share.Honest didn’t immediately reply to a request for comment.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
An up-and-coming gold exploration company in Quebec may hit the jackpot in what could end up being a story even some of the most seasoned investors only ever dream of
Investors who appreciate the fast pace of Bitcoin (XBT) and Ethereum (ETH) will like HIVE Blockchain Technologies (HVBTF). This stock can serve as a proxy for accounts that do not permit cryptocurrency trading, such as some retirement accounts. HIVE is involved in green energy, which is a red-hot market in 2021. Plus, HIVE now has a DeFi (decentralized finance) angle, which could enhance the company’s shareholder value even further. A Quick Look At HVBTF Stock Recently, HIVE’s stock has experienced lightning-fast price action. As recently as January of 2020, HVBTF stock was available for just 9 cents. It then soared to a 52-week high of $5.75 in February 2021. However, the share price has retraced to the $3 range since that time. (See HIVE stock analysis on TipRanks) This sector is prone to bouts of extreme volatility, so investors should be cautious. A small position in the stock could yield substantial returns – just make sure that you’re wearing your seat belt, as it could be a wild ride. A Green Energy Blockchain Leader Is it possible to invest in cryptocurrency mining and consider ESG (environmental, social and governance) factors at the same time? Cryptocurrency mining is notorious for using tremendous amounts of energy. Yet HIVE’s investor presentation confirms its commitment to clean, responsible crypto mining. HIVE conducts its crypto mining operations in cold climates because it is power-efficient, and therefore cost-efficient. The company mines for Ethereum and Bitcoin in Sweden, Iceland and Canada – some of the coldest regions in the world. This has contributed to improved profitability, with HIVE going from adjusted EBITDA of -$5 million in fiscal year 2019 to $7.8 million in fiscal year 2020. 2020 was the first year in which HIVE achieved profitability, and it has grown from there. Additionally, all of HIVE’s cryptocurrency mining facilities have been powered by green energy from day one. Further proving its commitment to going green, the company just acquired a massive data center in Canada with access to 50 megawatts of low-cost green power. Expanding Into DeFi Along with the company’s robust yet clean mining operations, HIVE is moving aggressively into the DeFi (decentralized finance) space. DeFi refers to financial applications built on blockchain technologies, which are meant to disrupt the traditional world of finance. The company is not building its own DeFi business from scratch, which would be a costly and time-consuming project. Instead, HIVE is engaging in a share swap with decentralized finance asset manager DeFi Technologies Inc. (DEFI). As a result of the share swap, HIVE will own around 5% of DeFi Technologies’ outstanding common shares, while DeFi Technologies will own roughly 1% of HIVE’s outstanding common shares. This partnership, according to the press release, will “provide HIVE with a strategic stake in DeFi Technologies and a broader partnership surrounding the DeFi ecosystem with a specific focus on the Ethereum based MEV space and developments surrounding it.” MEV refers to the amount of profit that cryptocurrency miners can extract from reordering and censoring transactions on the blockchain. In other words, this transaction will not only diversify HIVE’s business, but could also enhance HIVE’s profit potential as a cryptocurrency miner. Weighing All Of The Factors Looking at its TipRanks Smart Score, which is derived from 8 unique data sets, HIVE earns a 5. That means it is likely to perform in line with market averages. Takeaway For HIVE Blockchain Technologies and its shareholders, the deal with DeFi Technologies sounds like a win-win. Investors who are in the market for an ultra-efficient cryptocurrency miner with an ESG angle should find it in HIVE. To find other compelling plays in this fast-growing space, check out the Cryptocurrency Stock Comparison tool on TipRanks. Disclosure: On the date of publication, David Moadel did not have (either directly or indirectly) any positions in the securities mentioned in this article. Disclaimer: The information contained herein is for informational purposes only. Nothing in this article should be taken as a solicitation to purchase or sell securities.
Video game maker Roblox announced its Q1 2021 earnings for the first time as a public company.
Families can get up to $50 off their bill to stay connected during the pandemic.
A lackluster jobs report didn’t derail the markets last week. New jobs in April totaled only 266,000, far below the 978K expected, and the official unemployment rate, which had been predicted to come in at 5.8% actually ticked up slightly to 6.1%. Even so, the tech-weighted NASDAQ gained 0.88% in Friday’s session, the broader S&P 500 was up 0.75% at the end of the day. These gains brought the S&P to a new record level, with a year-to-date gain of 13%. The market’s growth so far this year has been broad-based, based as it is on a general economic reopening as the corona panic shrinks in the rear-view mirror. Broad-based market gains create a positive environment for growth stocks. Using the TipRanks database, we’ve pulled up three stocks that fit a profile: a Buy rating from Wall Street, recent share appreciation that strongly outperforms the overall markets, and considerable upside potential, indicating that they may still be undervalued. Here are the details. Crocs (CROX) We’ll start in footwear, where Crocs took the world by storm almost 20 years ago, when it first started selling its signature brand of foam clogs. The shoes were big, bright, and even tacky – but they caught on and succeeded, and the company has since branched out into more traditional footwear, including sandals, sneakers, and even dress shoes. The brand has grown popular with teens, who see it as an ‘ugly chic’ and retro – but have boosted sales. And boosted sales are what the game is all about. The company’s quarterly revenues hit their recent trough in the fourth quarter of 2019, and since then have recorded 5 consecutive quarter-over-quarter revenue gains, with last three also being year-over-year gains. The most recent quarterly reports, released last month for 1Q21, showed $460.1 million on the top line, a company record, and a 63% year-over-year gain. EPS, at $1.47, was down from Q4’s $2.69 – but up more than 800% from the 16 cents recorded in the year-ago quarter. That gain helped cap a year in which CROX shares have appreciated an impressive 374%, and are still trending upwards. Crocs’ overperformance has caught the eye of Piper Sandler analyst Erinn Murphy, who is ranked in the top 10% of Wall Street’s stock pros. “We applaud the Crocs' team for their continued execution, disciplined inventory management & account management and underlying reinvestments in the brand health. Too, with strong visibility into Q2 (sales forecast +60% to 70%) and 2H estimates moving up handily with solid orderbook plans to boot, we believe bears worried about the sustainability of the brand momentum will need to hibernate for another 12 months,” Murphy noted. To this end, Murphy gives CROX an Overweight (i.e. Buy) rating, and her $140 price target suggests it has a ~29% upside in the next 12 months. (To watch Murphy’s track record, click here) It’s clear that Wall Street generally agrees with the Piper Sandler take on Crocs. The stock has 8 recent reviews, which include 6 to Buy and 2 to Hold, giving the stock its Strong Buy consensus rating. The share price is $108.92, and the average target of $123.75 indicates room for ~14% growth in the year ahead. (See CROX stock analysis on TipRanks) Cleveland-Cliffs, Inc. (CLF) We’ll continue our look at growth stocks with Cleveland-Cliffs. This mining and steel company, based in Ohio, has four active iron mines in northern Minnesota and Michigan. The company started out as a miner, and in 2020 acquired two steelmaking firms, AK Steel and ArcelorMittal USA, and became both self-sufficient in the steel industry, from ground to foundry, and the largest North American producer of flat-rolled steel. The company has seen its shares rise dramatically in recent quarters, on the back of rising revenues. CLF is up 393% since this time one year ago, galloping past the S&P’s 44% one-year gain. Cleveland-Cliffs’ rise has come as the company has generated $1 billion-plus revenues for four quarters in a row. The most recent quarter, 1Q21, showed $4.02 billion on the top line. While slightly below analyst expectations, this total was up 84% from Q4, and almost 10x greater than the year-ago quarter’s $385.9 million. Looking at earnings, CLF showed a modest net profit of $41 million in the quarter, or 7 cents per share. This is a solid turnaround from the year-ago quarter’s net loss of $52 million, or 18 cents per share. The gains in revenue and earnings are considered a landmark for the company, starting its first full year as a self-sufficient iron miner and steel maker. In addition to starting the year on a positive note, the company also boasted liquidity of $1.8 billion. Lucas Pipes, 5-star analyst with B. Riley, writes of Cleveland-Cliffs: “With near-term cash flows expected to be robust ($2.3B expected for 2021), the company expects to use excess cash flow to aggressively reduce debt. We see low leverage as a strategic priority for the company at this time as it proves out the benefits of its fully integrated model. In our opinion, Cleveland-Cliffs represents the most attractive value in the space.” These comments back up Pipes’ Buy rating, and he sets a $24 price target that implies a 56% one-year upside potential. (To watch Pipes’ track record, click here) Overall, the Street’s take on CLF is currently split evenly down the middle. 3 Buys and 3 Holds add up to a Moderate Buy consensus rating. The average price target is $25.40 and implies that the analysts see the stock rising ~20% from current levels. (See CLF stock analysis on TipRanks) Atlas Air (AAWW) Last but not least is Atlas Air, a $2 billion player in the aviation industry. Atlas operates as a cargo airline and passenger charter service, and an aircraft lessor to other airlines, renting out planes along with air and ground crew services. The company controls a fleet of Boeing commercial aircraft, including 747s, 777s, 767s, and 737s, configured for a variety of roles. As can be imagined, Atlas saw business decline during the corona pandemic – but managed to weather the crisis due to the long-term nature of most of its leases. The top line is up 33% year-over-year for 1Q21, at $861.3 million. Earnings, at $3.05 per share, are positive, and while down from $6.20 in Q4 they are up 238% from the year-ago quarter. The company expects business to continue strong this year, as demand for air freight is exceeding supply given the fast pace of economic reopening. Over the past 12 months, Atlas Air has seen strong share growth, with the stock rising 108%. Yet, Truist’s 5-star analyst Stephanie Benjamin believes the stock has more room to grow. “We view AAWW’s diversified fleet and international reach favorably position the company to capitalize on increased air freight demand due to the global growth in e-commerce and ongoing supply chain disruptions. Furthermore, while AAWW was a clear “COVID beneficiary” we believe its increased focus on long-term contracts over the last year has fundamentally strengthened its business model and should provide greater revenue/earnings visibility going forward," Benjamin opined. Unsurprisingly, Benjamin rates the stock a Buy, with a $95 price target that implies an upside of 28% this year. (To watch Benjamin’s track record, click here) All in all, Wall Street agrees with Benjamin’s call on this. The stock has 3 recent reviews on file, and all are to Buy, making the Strong Buy consensus rating unanimous. With an average price target of $86.67 and a current trading price of $74.03, this stock shows a one-year upside of 17% (See AAWW stock analysis on TipRanks). To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.